Detalhe da pesquisa
1.
Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitors.
Nat Commun
; 13(1): 4785, 2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35970853